Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06275412 · ClinicalTrials.gov registry record · NA

Family Intervention for Black Teens With Type 1 Diabetes

A NA study of Type 1 Diabetes and Family Relations, sponsored by Wayne State University.

Recruiting
Registry status
NA
Development phase
216
Enrollment target
4
Study locations

NCT06275412 is a NA study of Type 1 Diabetes and Family Relations that is actively recruiting participants, run by Wayne State University. The registered enrollment target is 216 participants, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (74% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06275412, a NA study of Type 1 Diabetes and Family Relations, is actively recruiting participants, sponsored by Wayne State University.

RECRUITING
Registry status
NA
Development phase
216 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone). The intervention will also include new family intervention content (videoclips and text messages).

Interventions

  • BEHAVIORAL The 3Ms 2.0 Intervention
  • BEHAVIORAL Educational Attention Control (EAC)

Study Locations (4)

Tennessee

  • LeBonheur Children's Hospital - Memphis
  • University of Tennessee Health Science Center-Memphis - Memphis

District of Columbia

  • Children's National Hospital - Washington D.C.

Michigan

  • Wayne Pediatrics - Detroit

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2024-09-16
Est. Completion 2028-04-30
Phase NA

Sponsor

Wayne State University

163 total trials

What the Registry Record Tells You About NCT06275412

The ClinicalTrials.gov registry entry for NCT06275412 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (74% lower). The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which The 3Ms 2.0 Intervention is the first listed.

NCT06275412 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Tennessee, District of Columbia, Michigan.

Frequently Asked Questions

What is clinical trial NCT06275412 about?

NCT06275412 is a clinical study titled "Family Intervention for Black Teens With Type 1 Diabetes". The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black a...

What is the current status of trial NCT06275412?

This trial is currently recruiting. It is a NA study. The enrollment target is 216 participants. The study started on 2024-09-16. Estimated completion is 2028-04-30.

What conditions does trial NCT06275412 study?

This clinical trial studies the following conditions: Type 1 Diabetes, Family Relations.

What interventions are being tested in trial NCT06275412?

The interventions under investigation include: The 3Ms 2.0 Intervention (BEHAVIORAL), Educational Attention Control (EAC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06275412?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06275412 being conducted?

This trial has 4 study locations across District of Columbia, Michigan, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.